Navigation Links
For Kids With Down Syndrome, a 'Ray of Hope'
Date:11/19/2009

Study in mice could lead to treatment for learning deficits, researcher suggests,,

THURSDAY, Nov. 19 (HealthDay News) -- New research may provide the foundation for future medical treatment of memory deficits associated with Down syndrome.

The research was conducted in mice that were genetically engineered to have a condition similar to Down syndrome, a genetic disorder. It is still not clear if humans would benefit from the findings.

Still, the researchers found that mice with the syndrome-like condition could use their brains more effectively when the signaling of norepinephrine, a neurotransmitter that helps nerve cells communicate, was boosted.

"If you intervene early enough, you will be able to help kids with Down syndrome to collect and modulate information," Dr. Ahmad Salehi, the study's primary author, said in a news release from Stanford University Medical Center. "Theoretically, that could lead to an improvement in cognitive functions in these kids." Salehi, a research health science specialist at the Veterans Affairs Palo Alto Health Care System, in California, was a senior scientist at Stanford when the study was conducted.

The study found that the mice did better on cognitive tests such as nest-building -- in fact, as well as normal mice -- after getting drugs that boosted norepinephrine levels.

"We were very surprised to see that, wow, it worked so fast," Salehi said. The results were published Nov. 18 in Science Translational Medicine.

The study results give "a ray of hope and optimism for the Down syndrome community for the future," Dr. Melanie Manning, director of the Center for Down Syndrome at Lucile Packard Children's Hospital, said in the news release.

More information

The Nemours Foundation has more on Down syndrome.



-- Randy Dotinga



SOURCE: Stanford University Medical Center, news release, Nov. 18, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. ReachMD XM 157 Announces Medical Information Feature on Irritable Bowel Syndrome, Its Treatments, and the Role of Probiotics
2. The Sensory Research Center (SRC) Offers 2 for 1 Tickets for Benefit Concert Supporting Autism, Downs Syndrome, Cerebral Palsy and Other Disabilities.
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
6. Drug-free treatments offer hope for older people in pain
7. LOreal Paris Celebrates Ten Years of Hope and Healing
8. Researchers test old drug with new hopes for pre-eclampsia cure
9. Super Jake Foundation Offers Hope for Pediatric Cancer
10. Super Bowl Champion, Pro Bowler and Pittsburgh Steeler Alan Faneca to Host Sixth Annual Bid for Hope Auction
11. Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: